نتایج جستجو برای: coagulation factor VIII

تعداد نتایج: 893356  

Journal: :iranian journal of pediatric hematology and oncology 0
fatemeh sarkargar phd student of biochemistry, department of biology, faculty of science, payamnoor -university, tehran, ira mahta mazaheri associate professor of medical genetics (md-phd), department of genetics, faculty of medicine, shahid sadoughi universiسازمان های دیگر: mother and newborn health research center, shahid sadoughi university of medical science, yazd, iran hossein khodai expert laboratory of genetic, meybod genetic research center, meybod, iranسازمان اصلی تایید شده: دانشگاه پیام نور تهران (payame noor university) razieh sadat tabatabaei assistant professor of gynecology, department of gynecology and obstetrics, faculty of medicine, shahid sadoughi universسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences)

background: haemophilia a (ha) is an x-linked bleeding disorder caused by the absence or reduced activity of coagulation factor viii (fviii). coagulation factors are a group of related proteins that are essential for the formation of blood clots. the aim of this study was to genotype the coagulation factor viii gene mutations using inverse shifting pcr (is-pcr) in an iranian family with severe ...

ALI AKBAR POURFATHOLLAH, HABIBOLLAH ESMAILI, HASSAN MANSOURI TORGHABEH, MAHMOOD MAHMOODIAN SHOOSHTARI, ZAHRA REZAIE YAZDI,

Patients with coagulation factor(s) deficiency who use coagulation therapy are susceptible to forming inhibitors against coagulation factor(s). In this survey we detected factor V and VIII inhibitor in ten patients with combined deficiency of factors V and VIII from north east of Iran (Khorassan province). It was revealed in our survey that eight patients had both factor V and factor VIII i...

Journal: :medical journal of islamic republic of iran 0
hassan mansouri torghabeh from the 'experimental hematology and blood banking dept, medical sciences school, tarbiat modaresuniversity (t.m. u.), ali akbar pourfathollah from the 'experimental hematology and blood banking dept, medical sciences school, tarbiat modaresuniversity (t.m. u.), mahmood mahmoodian shooshtari the iranian blood transfusion organization research center, tehran zahra rezaie yazdi the departmentof internal medicine, mashhad medical sciences university, mashhad habibollah esmaili 4community medicine and public health department of mashhad medical sciences university, mashhad, iran

patients with coagulation factor(s) deficiency who use coagulation therapy are susceptible to forming inhibitors against coagulation factor(s). in this survey we detected factor v and viii inhibitor in ten patients with combined deficiency of factors v and viii from north east of iran (khorassan province). it was revealed in our survey that eight patients had both factor v and factor viii inhib...

Journal: :arya atherosclerosis 0
s asgary a poorshams gh naderi ah siadat n askari

abstract  introduction: during extrinsic coagulation pathway, a complex is developed between factor vii, calcium and tissue factor (a cell membrane lipoprotein that is exposed after cell injury). factor vii needs calcium and vitamin k for its biologic activation. coronary artery disease (cad) can be induced by increased level and activity of the coagulation factors vii, viii and ix. in postmeno...

ذوالفقاری, سیما , صادقی, معصومه , عسکری, نازیلا , عسگری, صدیقه , فاضلی, مریم , نادری, غلامعلی, پورشمس, اکرم ,

Background: During extrinsic coagulation pathway, a complex is developed between factor VII, calcium and tissue factor (a cell membrane lipoprotein that is exposed after cell injury). Factor VII needs calcium and vitamin K for its biologic activation. Coronary artery disease can be induced by increased level and activity of the coagulation factors VII, VIII and IX. In postmenopausal period, est...

Journal: :Haemostasis 1989
M Xi S Béguin H C Hemker

We report a study on the importance of factor IX activation in thromboplastin-dependent coagulation in plasma. Diluted, CaCl2-containing thromboplastin solutions at constant phospholipid concentration were used to trigger the coagulation in plasma from patients with congenital factor IX and factor VIII deficiency in the presence and absence of added factors IX and VIII, and the generation of th...

2012
Imen Kraiem Samira Hadhri Halima El Omri Raja Sassi Wiem Chaabani Souad Ennabli Hadef Skouri

R a Abstract. Production of factor VIII or factor IX inhibitors is a major complication limiting the efficiency of substitutive therapy in haemophiliacs. Moreover, viral infections, the second serious complication of replacement therapy, may be associated to the occurrence of antiphospholipid antibodies which paradoxically lead to thrombosis. We investigated the prevalence of coagulation inhibi...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1985
D N Fass R M Hewick G J Knutson M E Nesheim K G Mann

Blood coagulation factors V and VIII each serve cofactor functions with different vitamin K-dependent serine proteases of the coagulation cascade. Physical, physiologic, and kinetic data suggest analogous structures and functions for these two proteins. Proteolytically activated factor V (factor Va) is required for the efficient production of thrombin from prothrombin by factor Xa. Similarly, a...

2010
Hyun Ju Kim Won Sik Lee Young Jin Lee Hyun Soo Jun Su-Kil Seo Young-Don Joo

Acquired factor VIII deficiency is very rare, often fatal. It is associated with pregnancy, autoimmune diseases, malignancy, and drugs, although no underlying cause is found in 50%. A 49-year-old male was referred with right shoulder bruising. The coagulation test showed a prolonged activated partial thromboplastin time. The factor VIII level was less than 1%, and the factor VIII inhibitor anti...

2006
Mi Jung Kim A-Hyun Cho Young-Joo No Hee-Young Kim Jong S. Kim

Cerebral venous thrombosis (CVT) rarely recurs, and the factors associated with a recurrence remain unclear. Recently, however, elevated plasma coagulation factor VIII has been considered a factor related to recurrent venous thromboembolism. Here we report a patient who had recurrent CVT associated with significantly elevated levels of factor VIII despite the chronic use of an antiplatelet agen...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید